Chapter 2.3 Glucocorticoids and the immune response

Techniques in the Behavioral and Neural Sciences

Volumn 15, Issue PART 2, 2005, Pages 175-191

  Wiegers, G Jan ^a   Stec, Ilona E M ^a   Sterzer, Philipp ^b   Reul, Johannes M H M ^c  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

ACTH; adrenocorticotropin; Ag; antigen; BN; Brown Norway; CBG; ciliary neurotrophic factor receptor; CNTFR; corticosterone binding globulin; DA; Dark Agouti; delayed type hypersensitivity; DTH; EAE; experimental allergic encephalomyelitis; fetal thymic organ cultures; FTOC; G CSF; GAS; GC; GC increasing factor; General Adaptation Syndrome; GIF; glucocorticoid; GM CSF; granulocyte colony stimulating factor; granulocyte macrophage colony stimulating factor; HPA; hypothalamic pituitary adrenal; IFN; Ig; IL; immunoglobulin; interferon; interleukin; leukaemia inhibitory factor receptor; LIFR; lipopolysaccharide; LPS; macrophage inflammatory protein 1 ; major histocompatibility complex; MBP; MCMV; MHC; MIP1 ; MOG; murine cytomegalovirus; myelin basic protein; myelin oligodendrocyte glycoprotein; NF IL 6; nuclear factor IL 6; Obese Strain; OS; PBMC; PCC; peripheral blood mononuclear cells; pigeon cytochrome c; PPD; purified protein derivative; RANTES; regulated on activation, normal T cell expressed and secreted; SCW; streptococcal cell wall polysaccharide; T cell receptor; TCR; TEC; TGF ; thymic epithelial cell; TNF; transforming growth factor ; tumour necrosis factor

Indexed keywords

EID: 70350332133     PISSN: 09210709     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0921-0709(05)80055-0     Document Type: Chapter

References (124)

1. Addison T. On the Constitutional and Local Effects of Disease of the Suprarenal Capsules (1855), Highley, Norwell, MA
2. Almawi W.Y., Beyhum H.N., Rahme A.A., and Rieder M.J. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J. Leukoc. Biol. 60 (1996) 563-572
3. Ashwell J.D., Lu F.W., and Vacchio M.S. Glucocorticoids in T cell development and function. Annu. Rev. Immunol. 18 (2000) 309-345
4. Bakker J.M., Kavelaars A., Kamphuis P.J., Cobelens P.M., van Vugt H.H., van Bel F., and Heijnen C.J. Neonatal dexamethasone treatment increases susceptibility to experimental autoimmune disease in adult rats. J. Immunol. 165 (2000) 5932-5937
5. Barber A.E., Coyle S.M., Marano M.A., Fischer E., Calvano S.E., Fong Y., Moldawer L.L., and Lowry S.F. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J. Immunol. 150 (1993) 1999-2006
6. Baumann H., and Gauldie J. The acute phase response. Immunol. Today 15 (1994) 74-80
7. Bergsteindottir K., Brennan A., Jessen K.R., and Mirsky R. In the presence of dexamethasone, gamma interferon induces rat oligodendrocytes to express major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 89 (1992) 9054-9058
8. Berkenbosch F., van Oers J., Del Rey A., Tilders F., and Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 238 (1987) 524-526
9. Bertini R., Bianchi M., and Ghezzi P. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J. Exp. Med. 167 (1988) 1708-1712
10. Besedovsky H.O., and Sorkin E. Network of immune-neuroendocrine interactions. Clin. Exp. Immunol. 27 (1977) 1-12
11. Besedovsky H.O., and Del Rey A. Immune-neuroendocrine interactions: facts and hypotheses. Endocr. Rev. 17 (1996) 64-102
12. Besedovsky H.O., Sorkin E., Keller M., and Muller J. Changes in blood hormone levels during the immune response. Proc. Soc. Exp. Biol. Med. 150 (1975) 466-470
13. Besedovsky H.O., Del Rey A., and Sorkin E. Antigenic competition between horse and sheep red blood cells as a hormone-dependent phenomenon. Clin. Exp. Immunol. 37 (1979) 106-113
14. Besedovsky H.O., Del Rey A., and Sorkin E. Lymphokine-containing supernatants from con A-stimulated cells increase corticosterone blood levels. J. Immunol. 126 (1981) 385-387
15. Besedovsky H.O., Del Rey A., Sorkin E., and Dinarello C.A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233 (1986) 652-654
16. Blotta M.H., DeKruyff R.H., and Umetsu D.T. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J. Immunol. 158 (1997) 5589-5595
17. Bone R.C., Fisher Jr. C.J., Clemmer T.P., Slotman G.J., Metz C.A., and Balk R.A. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 317 (1987) 653-658
18. Brewer J.A., Kanagawa O., Sleckman B.P., and Muglia L.J. Thymocyte apoptosis induced by T cell activation is mediated by glucocorticoids in vivo. J. Immunol. 169 (2002) 1837-1843
19. Brezinschek H.P., Faessler R., Klocker H., Kroemer G., and Sgonc R. Analysis of the immune-encodrine feedback loop in the avian system and its alteration in chickens with spontaneous autoimmune thyroiditis. Eur. J. Immunol. 20 (1990) 2155-2159
20. Campos S.P., Wang Y., Koj A., and Baumann H. Divergent transforming growth factor-beta effects on IL-6 regulation of acute phase plasma proteins in rat hepatoma cells. J. Immunol. 151 (1993) 7128-7137
21. Carryer H., Sherrick D., and Gastineau C. Occurance of allergic disease in patients with adrenal cortical hypofunction. JAMA 172 (2001) 1356-1361
22. Cohen J.J. Glucocorticoid-induced apoptosis in the thymus. Semin. Immunol. 4 (1992) 363-369
23. Compton M.M., and Cidlowski J.A. Rapid in vivo effects of glucocorticoids on the integrity of rat lymphocyte genomic deoxyribonucleic acid. Endocrinology 118 (1986) 38-45
24. Constant S.L., and Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu. Rev. Immunol. 15 (1997) 297-322
25. Cronin L., Cook D.J., Carlet J., Heyland D.K., King D., Lansang M.A., and Fisher Jr. C.J. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit. Care Med. 23 (1995) 1430-1439
26. Cummings J.J., D'Eugenio D.B., and Gross S.J. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N. Engl. J. Med. 320 (1989) 1505-1510
27. Daynes R.A., and Araneo B.A. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur. J. Immunol. 19 (1989) 2319-2325
28. DeKruyff R.H., Fang Y., and Umetsu D.T. Corticosteroids enhance the capacity of macrophages to induce Th2 cytokine synthesis in CD4+ lymphocytes by inhibiting IL-12 production. J. Immunol. 160 (1998) 2231-2237
29. de Waal Malefyt R., Haanen J., Spits H., Roncarolo M.G., te Velde A., Figdor C., Johnson K., Kastelein R., Yssel H., and de Vries J.E. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174 (1991) 915-924
30. Dhabhar F.S., and McEwen B.S. Stress-induced enhancement of antigen-specific cell-mediated immunity. J. Immunol. 156 (1996) 2608-2615
31. Dhabhar F.S., and McEwen B.S. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc. Natl. Acad. Sci. USA 96 (1999) 1059-1064
32. Emilie D., Karray S., Crevon M.C., Vazquez A., and Galanaud P. B cell differentiation and interleukin 2 (IL-2): corticosteroids interact with monocytes to enhance the effect of IL-2. Eur. J. Immunol. 17 (1987) 791-795
33. Fassler R., Schauenstein K., Kroemer G., Schwarz S., and Wick G. Elevation of corticosteroid-binding globulin in obese strain (OS) chickens: possible implications for the disturbed immunoregulation and the development of spontaneous autoimmune thyroiditis. J. Immunol. 136 (1986) 3657-3661
34. Fernandez-Ruiz E., Rebollo A., Nieto M.A., Sanz E., Somoza C., Ramirez F., Lopez-Rivas A., and Silva A. IL-2 protects T cell hybrids from the cytolytic effect of glucocorticoids. Synergistic effect of IL-2 and dexamethasone in the induction of high-affinity IL-2 receptors. J. Immunol. 143 (1989) 4146-4151
35. Flower R.J., Parente L., Persico P., and Salmon J.A. A comparison of the acute inflammatory response in adrenalectomised and sham-operated rats. Br. J. Pharmacol. 87 (1986) 57-62
36. Franchimont D., Galon J., Vacchio M.S., Fan S., Visconti R., Frucht D.M., Geenen V., Chrousos G.P., Ashwell J.D., and O'Shea J.J. Positive effects of glucocorticoids on T cell function by up-regulation of IL-7 receptor alpha. J. Immunol. 168 (2002) 2212-2218
37. Frey F.J., Trost B., and Zimmermann A. Autoimmune adrenalitis, asthma and membranoproliferative glomerulonephritis. Am. J. Nephrol. 11 (1991) 341-342
38. Galon J., Franchimont D., Hiroi N., Frey G., Boettner A., Ehrhart-Bornstein M., O'Shea J.J., Chrousos G.P., and Bornstein S.R. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J. 16 (2002) 61-71
39. Giles K.M., Ross K., Rossi A.G., Hotchin N.A., Haslett C., and Dransfield I. Glucocorticoid augmentation of macrophage capacity for phagocytosis of apoptotic cells is associated with reduced p130Cas expression, loss of paxillin/pyk2 phosphorylation, and high levels of active Rac. J. Immunol. 167 (2001) 976-986
40. Gottschall P.E., Koves K., Mizuno K., Tatsuno I., and Arimura A. Glucocorticoid upregulation of interleukin 1 receptor expression in a glioblastoma cell line. Am. J. Physiol. 261 (1991) E362-E368
41. Green M., and Lim K.H. Bronchial asthma with Addison's disease. Lancet 1 (1971) 1159-1162
42. Gruber J., Sgonc R., Hu Y.H., Beug H., and Wick G. Thymocyte apoptosis induced by elevated endogenous corticosterone levels. Eur. J. Immunol. 24 (1994) 1115-1121
43. Guida L., O'Hehir R.E., and Hawrylowicz C.M. Synergy between dexamethasone and interleukin-5 for the induction of major histocompatibility complex class II expression by human peripheral blood eosinophils. Blood. 84 (1994) 2733-2740
44. Guo W.X., and Antakly T. AIDS-related Kaposi's sarcoma: evidence for direct stimulatory effect of glucocorticoid on cell proliferation. Am. J. Pathol. 146 (1995) 727-734
45. Hench P.S., Kendall E.C., Slocumb C.H., and Polley H.F. The effect of a hormone of the adrenal cortex (17-hydroxycorticosterone: compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Mayo Clinic Proc. 24 (1949) 181-197
46. Homo F., Duval D., Hatzfeld J., and Evrard C. Glucocorticoid sensitive and resistant cell populations in the mouse thymus. J. Steroid Biochem. Mol. Biol. 13 (1980) 135-143
47. Hu Y., Dietrich H., Herold M., Heinrich P.C., and Wick G. Disturbed immuno-endocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune disease. Int. Arch. Allergy Immunol. 102 (1993) 232-241
48. Ingle D.J. Effect of two steroid compounds on thymus weight of adrenalectomized rats. Proc. Soc. Exp. Biol. Med. 44 (1940) 174-175
49. Ingle D.J. Problems relating to the adrenal cortex. Endocrinology 31 (1942) 419-438
50. Ingle D.J. Permissibility of hormone action. A review. Acta Endocrinol. 17 (1954) 172-186
51. Iwata M., Hanaoka S., and Sato K. Rescue of thymocytes and T cell hybridomas from glucocorticoid-induced apoptosis by stimulation via the T cell receptor/CD3 complex: a possible in vitro model for positive selection of the T cell repertoire. Eur. J. Immunol. 21 (1991) 643-648
52. Jaffe H.L. The influence of the suprarenal gland on the thymus. III. Stimulation of the growth of the thymus gland following double suprarenalectomy in young rats. J. Exp. Med. 40 (1924) 753-760
53. Jenkinson E.J., Parnell S., Shuttleworth J., Owen J.J., and Anderson G. Specialized ability of thymic epithelial cells to mediate positive selection does not require expression of the steroidogenic enzyme p450scc. J. Immunol. 163 (1999) 5781-5785
54. Jondal M., Okret S., and McConkey D. Killing of immature CD4+ CD8+ thymocytes in vivo by anti-CD3 or 5′-(N-ethyl)-carboxamide adenosine is blocked by glucocorticoid receptor antagonist RU-486. Eur. J. Immunol. 23 (1993) 1246-1250
55. Kehrl J.H., Wakefield L.M., Roberts A.B., Jakowlew S., Alvarez-Mon M., Derynck R., Sporn M.B., and Fauci A.S. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163 (1986) 1037-1050
56. Kieffer J.D., and Ketchel M.M. Effects of adrenalectomy and antigenic stimulation on spleen weight in mice. Transplantation 11 (1971) 45-49
57. King L.B., Vacchio M.S., Dixon K., Hunziker R., Margulies D.H., and Ashwell J.D. A targeted glucocorticoid receptor antisense transgene increases thymocyte apoptosis and alters thymocyte development. Immunity 3 (1995) 647-656
58. Laue L., Kawai S., Brandon D.D., Brightwell D., Barnes K., Knazek R.A., Loriaux D.L., and Chrousos G.P. Receptor-mediated effects of glucocorticoids on inflammation: enhancement of the inflammatory response with a glucocorticoid antagonist. J. Steroid Biochem. Mol. Biol. 29 (1988) 591-598
59. Lechner O., Hu Y., Jafarian Tehrani M., Dietrich H., Schwarz S., Herold M., Haour F., and Wick G. Disturbed immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in murine lupus. Brain Behav. Immun. 10 (1996) 337-350
60. Lechner O., Dietrich H., Wiegers G.J., Vacchio M., and Wick G. Glucocorticoid production in the chicken bursa and thymus. Int. Immunol. 13 (2001) 769-776
61. Lechner O., Wiegers G.J., Oliveira-Dos-Santos A.J., Dietrich H., Recheis H., Waterman M., Boyd R., and Wick G. Glucocorticoid production in the murine thymus. Eur. J. Immunol. 30 (2000) 337-346
62. Linthorst A.C., Flachskamm C., Holsboer F., and Reul J.M.H.M. Local administration of recombinant human interleukin-1 beta in the rat hippocampus increases serotonergic neurotransmission, hypothalamic-pituitary-adrenocortical axis activity, and body temperature. Endocrinology 135 (1994) 520-532
63. Liu Y., Cousin J.M., Hughes J., Van Damme J., Seckl J.R., Haslett C., Dransfield I., Savill J., and Rossi A.G. Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J. Immunol. 162 (1999) 3639-3646
64. Lu F.W., Yasutomo K., Goodman G.B., McHeyzer-Williams L.J., McHeyzer-Williams M.G., Germain R.N., and Ashwell J.D. Thymocyte resistance to glucocorticoids leads to antigen-specific unresponsiveness due to 'holes' in the T cell repertoire. Immunity 12 (2000) 183-192
65. MacPhee I.A., Antoni F.A., and Mason D.W. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J. Exp. Med. 169 (1989) 431-445
66. McConkey D.J., Orrenius S., Okret S., and Jondal M. Cyclic AMP potentiates glucocorticoid-induced endogenous endonuclease activation in thymocytes. FASEB J. 7 (1993) 580-585
67. Munck A., and Brinck-Johnsen T. Specific and nonspecific physicochemical interactions of glucocorticoids and related steroids with rat thymus cells in vitro. J. Biol. Chem. 243 (1968) 5556-5565
68. Munck A., and Naray-Fejes-Toth A. Glucocorticoids and stress: permissive and suppressive actions. Ann. N. Y. Acad. Sci. 746 (1994) 115-130
69. Munck A., Guyre P.M., and Holbrook N.J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr. Rev. 5 (1984) 25-44
70. Nishio Y., Isshiki H., Kishimoto T., and Akira S. A nuclear factor for interleukin-6 expression (NF-IL6) and the glucocorticoid receptor synergistically activate transcription of the rat alpha 1-acid glycoprotein gene via direct protein-protein interaction. Mol. Cell. Biol. 13 (1993) 1854-1862
71. Obexer P., Certa U., Kofler R., and Helmberg A. Expression profiling of glucocorticoid-treated T-ALL cell lines: rapid repression of multiple genes involved in RNA-, protein- and nucleotide synthesis. Oncogene 20 (2001) 4324-4336
72. Oursler M.J., Riggs B.L., and Spelsberg T.C. Glucocorticoid-induced activation of latent transforming growth factor-beta by normal human osteoblast-like cells. Endocrinology 133 (1993) 2187-2196
73. Pazirandeh A., Xue Y., Rafter I., Sjovall J., Jondal M., and Okret S. Paracrine glucocorticoid activity produced by mouse thymic epithelial cells. FASEB J. 13 (1999) 893-901
74. Pietzko D., Zohlnhofer D., Graeve L., Fleischer D., Stoyan T., Schooltink H., Rose-John S., and Heinrich P.C. The hepatic interleukin-6 receptor. Studies on its structure and regulation by phorbol 12-myristate 13-acetate-dexamethasone. J. Biol. Chem. 268 (1993) 4250-4258
75. Purton J.F., Boyd R.L., Cole T.J., and Godfrey D.I. Intrathymic T cell development and selection proceeds normally in the absence of glucocorticoid receptor signaling. Immunity 13 (2001) 179-186
76. Purton J.F., Zhan Y., Liddicoat D.R., Hardy C.L., Lew A.M., Cole T.J., and Godfrey D.I. Glucocorticoid receptor deficient thymic and peripheral T cells develop normally in adult mice. Eur. J. Immunol. 32 (2002) 3546-3555
77. Ramirez F., Fowell D.J., Puklavec M., Simmonds S., and Mason D. Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. J. Immunol. 156 (1996) 2406-2412
78. Richards D.F., Fernandez M., Caulfield J., and Hawrylowicz C.M. Glucocorticoids drive human CD8(+) T cell differentiation towards a phenotype with high IL-10 and reduced IL-4, IL-5 and IL-13 production. Eur. J. Immunol. 30 (2001) 2344-2354
79. Rolfe F.G., Hughes J.M., Armour C.L., and Sewell W.A. Inhibition of interleukin-5 gene expression by dexamethasone. Immunology 77 (1992) 494-499
80. Ruzek M.C., Miller A.H., Opal S.M., Pearce B.D., and Biron C.A. Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J. Exp. Med. 185 (1997) 1185-1192
81. Ruzek M.C., Pearce B.D., Miller A.H., and Biron C.A. Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection. J. Immunol. 162 (1999) 3527-3533
82. Sanchez-Cuenca J., Martin J.C., Pellicer A., and Simon C. Cytokine pleiotropy and redundancy - gp130 cytokines in human implantation. Immunol. Today 20 (1999) 57-59
83. Sapolsky R., Rivier C., Yamamoto G., Plotsky P., and Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238 (1987) 522-524
84. Sapolsky R.M., Romero L.M., and Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 21 (2001) 55-89
85. Sayers G. The adrenal cortex and homeostasis. J. Clin. Invest. 76 (1950) 1755-1764
86. Schauenstein K., Fassler R., Dietrich H., Schwarz S., Kroemer G., and Wick G. Disturbed immune-endocrine communication in autoimmune disease: lack of corticosterone response to immune signals in obese chickens with spontaneous autoimmune thyreoiditis. J. Immunol. 139 (1987) 1830-1833
87. Schaumburg B.P., and Bojesen E. Specificity and thermodynamic properties of the corticosteroid binding to a receptor of rat thymocytes in vitro. Biochim. Biophys. Acta 170 (1968) 172-188
88. Schooltink H., Schmitz Van de Leur H., Heinrich P.C., and Rose John S. Up-regulation of the interleukin-6-signal transducing protein (gp130) by interleukin-6 and dexamethasone in HepG2 cells. FEBS Lett. 297 (1992) 263-265
89. Sei Y., Yoshimoto K., McIntyre T., Skolnick P., and Arora P.K. Morphine-induced thymic hypoplasia is glucocorticoid-dependent. J. Immunol. 146 (1991) 194-198
90. Selye H. Thymus and adrenals in the response of the organism to injuries and intoxications. Br. J. Exp. Pathol. 17 (1936) 234-248
91. Selye H. The general adaptation syndrome and the diseases of adaptation. J. Clin. Endocrinol. Metab. 6 (1946) 117-230
92. Shek P.N., and Sabiston B.H. Neuroendocrine regulation of immune processes: change in circulating corticosterone levels induced by the primary antibody response in mice. Int. J. Immunopharmacol. 5 (1983) 23-33
93. Shieh J.H., Peterson R.H., and Moore M.A. Cytokines and dexamethasone modulation of IL-1 receptors on human neutrophils in vitro. J. Immunol. 150 (1993) 3515-3524
94. Smith K.A. Interleukin-2: inception, impact, and implications. Science 240 (1988) 1169-1176
95. Stefferl A., Linington C., Holsboer F., and Reul J.M.H.M. Susceptibility and resistance to experimental allergic encephalomyelitis: relationship with hypothalamic-pituitary-adrenocortical axis responsiveness in the rat. Endocrinology 140 (1999) 4932-4938
96. Stefferl A., Storch M.K., Linington C., Stadelmann C., Lassmann H., Pohl T., Holsboer F., Tilders F.J., and Reul J.M.H.M. Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone. Endocrinology 142 (2001) 3616-3624
97. Stellato C., Beck L.A., Gorgone G.A., Proud D., Schall T.J., Ono S.J., Lichtenstein L.M., and Schleimer R.P. Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. J. Immunol. 155 (1995) 410-418
98. Sternberg E.M., Hill J.M., Chrousos G.P., Kamilaris T., Listwak S.J., Gold P.W., and Wilder R.L. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc. Natl. Acad. Sci. USA 86 (1989) 2374-2378
99. Sternberg E.M., Young W.S., Bernardini R., Calogero A.E., Chrousos G.P., Gold P.W., and Wilder R.L. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc. Natl. Acad. Sci. USA 86 (1989) 4771-4775
100. Takasu N., Komiya I., Nagasawa Y., Asawa T., and Yamada T. Exacerbation of autoimmune thyroid dysfunction after unilateral adrenalectomy in patients with Cushing's syndrome due to an adrenocortical adenoma. N. Engl. J. Med. 322 (1990) 1708-1712
101. Tausk M. In: Hormon D. (Ed). Hat die Nebenniere tatsächlich eine Verteidigungsfunction? (1951), Organon, London 1-24
102. Tehrani M.J., Hu Y., Marquette C., Dietrich H., Haour F., and Wick G. Interleukin-1 receptor deficiency in brains from NZB and (NZB/NZW)F1 autoimmune mice. J. Neuroimmunol. 53 (1994) 91-99
103. The Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N. Engl. J. Med. 317 (1987) 659-665
104. Tsunawaki S., Sporn M., Ding A., and Nathan C. Deactivation of macrophages by transforming growth factor-beta. Nature 334 (1988) 260-262
105. Vacchio M.S., and Ashwell J.D. Thymus-derived glucocorticoids regulate antigen-specific positive selection. J. Exp. Med. 185 (1997) 2033-2038
106. Vacchio M.S., Papadopoulos V., and Ashwell J.D. Steroid production in the thymus: implications for thymocyte selection. J. Exp. Med. 179 (1994) 1835-1846
107. VanOtteren G.M., Standiford T.J., Kunkel S.L., Danforth J.M., Burdick M.D., Abruzzo L.V., and Strieter R.M. Expression and regulation of macrophage inflammatory protein-1 alapha by murine alveolar and peritoneal macrophages. Am. J. Respir. Cell. Mol. Biol. 10 (1994) 8-15
108. Vella A., Teague T.K., Ihle J., Kappler J., and Marrack P. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4. J. Exp. Med. 186 (1997) 325-330
109. Vella A.T., Dow S., Potter T.A., Kappler J., and Marrack P. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc. Natl. Acad. Sci. USA 95 (1998) 3810-3815
110. Wang W., Wykrzykowska J., Johnson T., Sen R., and Sen J. A NF-kappa B/c-myc-dependent survival pathway is targeted by corticosteroids in immature thymocytes. J. Immunol. 162 (1999) 314-322
111. Wells B.B., and Kendall A. A qualitative difference in the effect of compounds separated from the adrenal cortex on distribution of electrolytes and on atrophy of the adrenal and thymus glands of rats. Mayo Clinic Proc. 15 (1940) 133-139
112. White A., and Dougherty T.F. The pituitary adrenotrophic hormone control of the rate of release of serum globulins from lymphoid tissue. Endocrinology 36 (1945) 207-217
113. Wick G., Brezinschek H.P., Hala K., Dietrich H., Wolf H., and Kroemer G. The obese strain of chickens: an animal model with spontaneous autoimmune thyroiditis. Adv. Immunol. 47 (1989) 433-500
114. Wick G., Hu Y., Schwarz S., and Kroemer G. Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases. Endocr. Rev. 14 (1993) 539-563
115. Wick G., Sgonc R., and Lechner O. Neuroendocrine-immune disturbances in animal models with spontaneous autoimmune diseases. Ann. N. Y. Acad. Sci. 840 (1998) 591-598
116. Wiegers G.J., and Reul J.M.H.M. Induction of cytokine receptors by glucocorticoids: functional and pathological significance. Trends Pharmacol. Sci. 19 (1998) 317-321
117. Wiegers G.J., Labeur M.S., Stec I.E.M., Klinkert W.E.F., Holsboer F., and Reul J.M.H.M. Glucocorticoids accelerate anti-T cell receptor-induced T cell growth. J. Immunol. 155 (1995) 1893-1902
118. Wiegers G.J., Stec I.E.M., Klinkert W.E.F., and Reul J.M.H.M. Glucocorticoids regulate TCR-induced elevation of CD4: functional implications. J. Immunol. 164 (2000) 6213-6220
119. Wiegers G.J., Knoflach M., Bock G., Niederegger H., Dietrich H., Falus A., Boyd R., and Wick G. CD4(+)CD8(+)TCR(low) thymocytes express low levels of glucocorticoid receptors while being sensitive to glucocorticoid-induced apoptosis. Eur. J. Immunol. 31 (2001) 2293-2301
120. Wu C.Y., Wang K., McDyer J.F., and Seder R.A. Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J. Immunol. 161 (1998) 2723-2730
121. Wu C.Y., Fargeas C., Nakajima T., and Delespesse G. Glucocorticoids suppress the production of interleukin 4 by human lymphocytes. Eur. J. Immunol. 21 (1991) 2645-2647
122. Wu C.Y., Sarfati M., Heusser C., Fournier S., Rubio Trujillo M., Peleman R., and Delespesse G. Glucocorticoids increase the synthesis of immunoglobulin E by interleukin 4-stimulated human lymphocytes. J. Clin. Invest. 87 (1991) 870-877
123. Zacharchuk C.M., Mercep M., Chakraborti P.K., Simons Jr. S.S., and Ashwell J.D. Programmed T lymphocyte death. Cell activation- and steroid-induced pathways are mutually antagonistic. J. Immunol. 145 (1990) 4037-4045
124. Zieg G., Lack G., Harbeck R.J., Gelfand E.W., and Leung D.Y. In vivo effects of glucocorticoids on IgE production. J. Allergy Clin. Immunol. 94 (1994) 222-230